Therapeutic Nano-Optic Endoscope for Detection and Treatment of COVID-19

用于检测和治疗 COVID-19 的治疗性纳米光学内窥镜

• 批准号: 549913-2020
• 负责人: Pahlevaninezhad, Majid
• 金额: $ 3.64万
• 依托单位: Queen's University
• 依托单位国家: 加拿大
• 项目类别: Alliance Grants
• 财政年份: 2020
• 资助国家: 加拿大
• 起止时间: 2020-01-01 至 2021-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=701365
• 关键词: Therapeutic; Nano; Optic; Endoscope; Detection

Due to the global pandemic caused by the Novel Coronavirus (COVID-19), there is a paramount need to treat symptoms, find cures, and reduce/contain the virus's continuous spread. The most life-threatening symptoms of COVID-19 result in severe respiratory failure due to pneumonia complications. While antiviral treatments and vaccines are under development globally, patients in critical condition cannot wait. It usually takes one to two years to develop vaccines, and cases continue to present with severe complications requiring immediate, life-saving intervention in the meantime. Thus, this research proposes to develop a therapeutic endoscopic imaging and treatment device and distribute the resultant nano-optic endoscope to treat the severe respiratory failure associated with COVID-19, to supply hospitals with a device to save lives while awaiting the medical community's vaccine. Genoptic will be commercializing the results of this research and Harvard University will be the academic collaborator.

由于新型冠状病毒（COVID-19）引起的全球大流行，迫切需要治疗症状，寻找治疗方法，并减少/遏制病毒的持续传播。COVID-19最危及生命的症状是肺炎并发症导致的严重呼吸衰竭。虽然全球正在开发抗病毒治疗和疫苗，但危重患者不能等待。开发疫苗通常需要一到两年的时间，并且病例继续出现严重并发症，需要立即采取挽救生命的干预措施。因此，本研究建议开发一种治疗性内窥镜成像和治疗装置，并将其分发给治疗COVID-19相关的严重呼吸衰竭的纳米光学内窥镜，为医院提供一种在等待医学界疫苗的同时拯救生命的装置。